openPR Logo
Press release

Aptamer Market to Reflect Impressive Growth Rate by 2025

08-10-2018 08:35 PM CET | Health & Medicine

Press release from: Transparency Market Research

Aptamer Market to Reflect Impressive Growth Rate by 2025

The global Aptamer Market was valued at approximately US$ 1.0 Bn in 2016 is projected to register cumulative annual growth rate (CAGR) of over 20.0% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Aptamer Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that surge in interest of research activity in the field of aptamer technology is likely to spur the demand of aptamer in the coming years (2017 to 2025). As key players introduce their new aptamer services for different application in developed markets such a North America and Western Europe, these regions are likely to account for dominating share of the global aptamer market. Demands for new diagnostic assay and increasing research activity in emerging markets such as China and Japan is likely to boost growth of Asia Pacific aptamer market at a CAGR of around 21.0% from 2017 to 2025.

Inadequate Regulatory Policies and Ethical Issues Related To Aptamer Development Can Restrain Global Market Expansion

Aptamer can be used as alternative to antibodies for various application. There is no formal regulatory guideline, which specifically addresses the quality expectation of aptamers. The regulatory expectation of aptamer-based drugs is still evolving. Several countries in Europe have tedious documentation processes for starting clinical trials of aptamers. For example, in Europe, the EU Clinical Trial Directive 2001/20/ EC is mandatory for initiation of aptamer clinical trials. However, the region has not developed any oligonucleotide specific guideline that can address the general requirements for the quality of aptamer clinical trials. Moreover, lack of universal rules for the application of aptamers in bioassays, which is well established when working with antibodies, restrains growth of global aptamer market.

Request to View Sample of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1335

Other Selection Techniques (e.g. X- Aptamer, MARAS etc.) to Lose Market Share

The report offers detailed segmentation of global aptamers market based on material type, selection technique and applications. Among the selection technique studied, SELEX technique segment is poised to account for leading share of the global market during the forecast period from 2017 to 2025. SELEX technique is likely to get boost for the modification of existing SELEX process, and available of the new updated SELEX technique like CE-SELEX, M- SELEX etc. which overcome the certain limitation for aptamer selection. The other technique (X-aptamer, MARAS technique etc.) segment is anticipated to lose its market share during the forecast period, and is expected to hold a share of ~18.0% by 2025 from ~21% in 2016. Availability of upgraded SELEX technique and lack of selection of high affinity ligands as compare to SELEX technique are factors likely to hamper this segment.

Diagnostics & Research: Top Two Application Areas of Aptamer

Among applications, research segment is projected to hold dominant share of global aptamer market during the forecast period and is likely to expand at CAGR more than 21.0% from 2017 to 2025. Major factors responsible for the dominance of this segment are efforts by several key players to develop new aptamers for research and development applications. For example, Aptagen, LLC has developed aptabodies (patent pending) that overcome the limitation of traditional pharmaceutical drug discovery process. The Aptabody technology demands shorter development time and offers effective Adsorption, Distribution, Metabolism and Excretion (ADME) properties due to unique chemical properties. Aptabodies are formed by hybridization of two DNA aptamers and allow detection of human thrombin effectively compared to traditional aptamers. In addition, aptabodies represent new area of development for next generation pharmaceuticals with improved pharmacokinetics and pharmacodynamic. Diagnostics segment, accounted for more than 30.0% share of global aptamer market in 2016, in terms of value. It is anticipated to have substantial growth and account for approximately 33.8% of market share by 2025.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1335

Asia Pacific to Resister Exponential Growth and Offer Huge Incremental Opportunity

In terms of value, North America was leading contributor in global aptamer market in 2016. High level of research activity in the U.S. is one of the contributing factor for major share of the North America market. Furthermore, presence of several key players such as Aptagen, Inc., Regado Biosciences, Inc. and Somalogic, Inc. has resulted in increased investment in research and development of novel aptamers. Thus, presence of these players would help the aptamers market in North America to grow rapidly during the forecast period Pharmaceutical research and development spending in emerging markets such as China and India are rising, which is fueling the expansion of Asia Pacific aptamer market. Regaining economic growth in Latin American markets such as Brazil is augmenting research and development activity, spending is increasing in diagnosis and treatment of various diseases in this region. This factor is likely to propel Latin America cardiovascular drugs market at CAGR of 19.0% from 2017 to 2025.

Key Players such as Somalogic, Inc., Aptagen, Inc, and Aptamer Group Limited are Likely to Continue to Lead the Global Aptamer Market

The report also provide profiles of leading players operating in global aptamer market include AM Biotech, Aptagen, LLC., Aptamer Group, Aptamer Sciences, Inc., Base Pair Biotechnologies, CD Genomics, NeoVentures Biotechnology Inc., NAXXON Pharma, Aptus Biotech, TriLink BioTechnologies, LLC., and Pfizer Inc. Expansion of aptamer based products portfolio through improving existing drugs and developing new drug molecules is one of the key strategy adopted by many key players, recent developing drugs such as NOX-E36 for treating type 2 diabetes by NAXXON Pharma and other key players reflect these strategies.

View Report -

https://www.transparencymarketresearch.com/aptamers-market.html

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Aptamer Market to Reflect Impressive Growth Rate by 2025 here

News-ID: 1174305 • Views: 332

More Releases from Transparency Market Research

Precooked Corn Flour Market to reach US$ 3 Bn by 2029
According to a new study by Transparency Market Research, sales of precooked corn flour is expected to exceed 1.1 million metric tons in 2019, and record a Y-o-Y growth of ~5% in 2020. The rising demand for bakery products in the food industry is fueling the demand for precooked corn flour. Rising Awareness about Benefits of Precooked Corn Flour to Drive Market Increasing number of manufacturers are developing food products that offer
Infused Dried Fruits Market to Reach Valuation of ~US$ 3.2 Bn By 2029
Infused Dried Fruits Market: Introduction A recent study published by Transparency Market Research on the infused dried fruits market includes global industry analysis and opportunity assessment for 2019-2029. The global infused dried fruits market was valued at ~US$ 1,954 Mn in 2019. The market is projected to expand at a CAGR of ~5.1%, to reach ~US$ 3.2 Bn by 2029. Increasing Use of Infused Dried Fruit Ingredients as Natural Sweeteners Fuel Growth Infused
Isomaltulose Market to Reach Valuation of ~US$ 1 Bn By 2030
Isomaltulose Market: Introduction A recent study published by Transparency Market Research on the isomaltulose market includes global industry analysis and opportunity assessment for 2020-2030. Revenue generated from the global Isomaltulose market was valued at ~US$ 711.1 Mn in 2020, which is estimated to expand at a CAGR of ~5%, to reach US$ 1 Bn by 2030. Rising Demand for Non-cariogenic Sugar to Augment Market Growth Non-cariogenic sugar demand, especially from the food &
Low Density Polyethylene (LDPE) Foams Market Forecast 2030
Albany, NY - Low Density Polyethylene (LDPE) Foams Market: Introduction The global low density polyethylene (LDPE) foams market was valued at ~US$ 1.5 Bn in 2019 and is anticipated to expand at a CAGR of ~5% during the forecast period. The global LDPE foams (LDPE) market is expected to expand at a rapid pace during the forecast period, due to the increase in penetration of LDPE foams in various sectors, particularly packaging,

All 5 Releases


More Releases for Aptamer

What's Driving Aptamers Market Trends? Key Company Profiled In LLC, Aptagen, LLC …
Aptamers are oligonucleotides or peptide molecules that bind to target lipid, protein, or nucleic acid molecules with a high specificity. Aptamers are generated rapidly and applied in the inhibition, specific detection, and characterization of proteins. Aptamers can be used as detection reagents, pharmaceutical leads, and functional proteomic levels with antibodies, small molecules, and other aptamers. Aptamers can be engineered to have higher affinity and specificity to large number of targets.
Aptamers Market Latest Innovation in 2019 by SOMALOGIC, APTAMER GROUP, APTAMER S …
The global Aptamers market has been estimated to reach USD 401.30 million in 2023. The market is expected to register a CAGR of 17.89% during the forecast period 2018 to 2023. North America dominates the market due to the increasing technological advancements. Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16739 Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”. Advancements in the field of aptamer
Aptamers Market: Peptide Segment Shows High Tides || Key Players: Base Pair Biot …
The global aptamers market shows significant growth rate during the period of forecast owing to many factors such as high investments in biopharmaceutical and pharmaceutical companies, technological advancements and increased research and development. The added benefits of aptamers such as their fast generation as compared to antibiotics which helps in rapid treatment of diseases and drug discoveries also supports the growth of the global aptamer market. This Fact.MR report analyzes the expansion of global aptamers
Aptamers Market SWOT Analysis to 2026 Top Companies AM Biotechnologies, LLC, Apt …
Aptamers are oligonucleotides or peptide molecules that bind to target lipid, protein, or nucleic acid molecules with a high specificity. Aptamers are generated rapidly and applied in the inhibition, specific detection, and characterization of proteins. Aptamers can be used as detection reagents, pharmaceutical leads, and functional proteomic levels with antibodies, small molecules, and other aptamers. Aptamers can be engineered to have higher affinity and specificity to large number of targets.
Aptamer Market 2018 Analysis and Growth by Top Key Players- NewVentures Biotechn …
The report “Global Aptamer by Manufacturers, Regions, Type and Application” highlights key dynamics of Aptamer Market. The potentiality of this sector has been examined along with the significant challenges and growth opportunities. The present market scenario and future predictions of the sector has also been studied in-depth in this report. The report also provides the key market players that are assessed on numerous parameters such as manufacturer’s summary, revenue generation,
Aptamer Market Research and Comparison of Major Players - AM Biotech, Aptagen, A …
Aptamers are chemically synthesized single-standard oligonucleotides. Aptamers offer relative cost advantage and are developed through more reliable process than monoclonal antibodies. The global aptamer market was valued approximately US$ 1.0 Bn in 2016 and is anticipated to register CAGR of over 20.0% from 2017 to 2025 to reach value of approximately US$ 5.0 Bn by 2025.  Advancement in technologies for selection of aptamer and increasing interest of research scientists in